Brief: Vector Science And Therapeutics Corp. Signs Amended, 10-Year Manufacturing And Testing Agreement With Lyogenesis Holdings
17/08/2026 13:09
BRIEF-Vector Science And Therapeutics Corp. Signs Amended, 10-Year Manufacturing And Testing Agreement With Lyogenesis Holdings Aug 17 (Reuters) - Vector Science and Therapeutics Corp PAIN.V:
VECTOR SCIENCE AND THERAPEUTICS CORP. SIGNS AMENDED, 10-YEAR MANUFACTURING AND TESTING AGREEMENT WITH LYOGENESIS HOLDINGS
VECTOR SCIENCE AND THERAPEUTICS CORP: FINANCIAL AND OTHER COMMERCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED
VECTOR SCIENCE AND THERAPEUTICS CORP - LYOGENESIS PLUS 1 TO REMAIN EXCLUSIVE MANUFACTURER FOR VST UNDER CGMP IN WISCONSIN
Source text: ID:nPnbZZwfHa
Further company coverage: PAIN.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vector Science and Therapeutics
See all newsBrief: Vector Science And Therapeutics Corp. Signs Amended, 10-Year Manufacturing And Testing Agreement With Lyogenesis Holdings
Brief: Vector Science And Therapeutics Corp. Signs Amended, 10-Year Manufacturing And Testing Agreement With Lyogenesis Holdings
Brief: Vector Science & Therapeutics Expects To Announce Distributor Partnerships In Coming Quarters
Brief: Vector Science & Therapeutics Names Dexter Fowler As Chief Athletic Officer For Its Valor Platform
Brief: Vector Science And Therapeutics Enters Option To Buy Up To 15% Of Lyogenesis Plus For Up To $1 Million